Author:
Cvjetković Bošnjak,Bibić Željko,Kuljančić Dušan
Abstract
Introduction: Serotonin syndrome is a rare but potentially life-threatening condition. In most cases, this complication is caused by taking two serotonergic medications simultaneously, leading to excessive serotonin concentration in the body. Selective serotonin reuptake inhibitors (SSRIs), selective serotonin and norepinephrine reuptake inhibitors (SNRIs), as well as irreversible monoamine oxidase inhibitors (MAOIs) and their combination with other serotonergic substances, are associated with symptoms of serotonin syndrome. Case study: A patient who was prescribed sertraline (an SSRI) for a depressive episode suffered fractures in a traffic accident during the treatment, and tramadol was prescribed for her pain. Since both drugs tend to increase serotonin levels in the body, a complication in the form of serotonin syndrome developed. With timely recognition and treatment, the symptoms of serotonin syndrome resolved without lasting consequences. Conclusion: Numerous drugs and substances can induce serotonin syndrome, often in combination with antidepressants. Therefore, it is of great importance that doctors are aware of comorbid conditions that necessitate the use of the mentioned drugs in order to prevent serotonin syndrome. If it does occur, adequate and successful treatment is crucial.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference22 articles.
1. Fricchione GL, Beach SR, Huffman JC, Bush G, Stern TA. Life-threatening conditions in psychiatry: catatonia, neuroleptic malignant syndrome and serotonin syndrome. In: Stern TA, Fava M, Wilens TE, Rosenbaum JF, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 2nd ed., 2015;
2. Meehan TJ. Care of the poisoned patient. In: Walas RM, Hockberger RS, Gausche Hill M, eds Rosens Emegency Medicine: Concepts and Clinical Practice. 10 th .ed. Philadelphia PA: Elsevier; 2023: chap 135. doi: 10.5070/M561051830;
3. Sporer KA. The Serotonin Syndrome. Implicated drugs, pathophysiology and management. Drug Saf. 1995; 13(2): 94-104. doi: 10.2165/00002018-199513020-00004;
4. Dunkley EJ, Isbister GK, Sibri HD, Dawson AH,Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. OJM. 2003; 96 (9): 635-42. doi: 10.1093/qjmed/hcg109;
5. Gillman PK. The serotonin syndrome and its treament. J. Psychopharmacol. 1999 (Oxford); 13(1): 100-9. doi: 10.1177/026988119901300111;